中国学者近期发表的论文
1.	Challenges and Opportunities With Oncology Drug Development in China. Author: Bajaj G1, Gupta M1, Wang HH2, Barrett JS3, Tan M2, Rupalla K2, Bertz R1, Sheng J1. Journal: Clin Pharmacol Ther. 2019 Feb;105(2):363-375. doi: 10.1002/cpt.1017. Epub 2018 Mar 8.    PubMed      DOI
2.	The Medication Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Asians: The Major Drug Causality and Comparison With the US FDA Label. Author: Wang YH1,2, Chen CB1,2,3,4,5,6,7, Tassaneeyakul W8, Saito Y9, Aihara M10, Choon SE11, Lee HY12,13, Chang MM14, Roa FD15, Wu CW16, Zhang J17, Nakkam N8, Konyoung P18, Okamoto-Uchida Y9, Cheung CM14, Huang JW17, Ji C17, Cheng B17, Hui RC1,2,3, Chu CY19, Chen YJ20, Wu CY21, Hsu CK22, Chiu TM23, Huang YH1,2,3, Lu CW1,2,3,4, Yang CY1,2,3, Lin YT1,2,3, Chi MH1,2,3, Ho HC1,2,3, Lin JY1,2,3, Yang CH1,2,3, Chang YC1,2,3, Su SC1,2,5, Wang CW1,2,5, Fan WL5, Hung SI24, Chung WH1,2,3,4,5,6,7; Asian Severe Cutaneous Adverse Reaction Consortium. Journal: Clin Pharmacol Ther. 2019 Jan;105(1):112-120. doi: 10.1002/cpt.1071. Epub 2018 Aug 9.    PubMed      DOI
3.	S-Nitrosylation of Prostacyclin Synthase Instigates Nitrate Cross-Tolerance In Vivo. Author: Zhou SN1, Lu JX2, Wang XQ1, Shan MR1, Miao Z1, Pan GP2, Jian X2, Li P2, Ping S2, Pang XY1, Bai YP3, Liu C4, Wang SX1,2,4. Journal: Clin Pharmacol Ther. 2019 Jan;105(1):201-209. doi: 10.1002/cpt.1094. Epub 2018 Aug 1.    PubMed      DOI
4.	Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy. Author: Beumer JH1,2,3, Chu E1,3, Allegra C4, Tanigawara Y5, Milano G6, Diasio R7,8, Kim TW9, Mathijssen RH10, Zhang L11, Arnold D12, Muneoka K13, Boku N14, Joerger M15. Journal: Clin Pharmacol Ther. 2019 Mar;105(3):598-613. doi: 10.1002/cpt.1124. Epub 2018 Sep 11.    PubMed      DOI
5.	Clinical Factors and Rate of Cough During Angiotensin-Converting Enzyme Inhibitor Treatment. Author: Ren H1,2,3, Luo JQ4, Shu Y5, Zhou HH1,2,3, Zhang W1,2,3. Journal: Clin Pharmacol Ther. 2019 Mar;105(3):566. doi: 10.1002/cpt.1218. Epub 2018 Sep 18.    PubMed      DOI
6.	HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians. Author: Su SC1,2, Chen CB1,2,3,4,5,6, Chang WC2, Wang CW2,5,6, Fan WL1, Lu LY2,3, Nakamura R7, Saito Y7, Ueta M8, Kinoshita S8, Sukasem C9,10, Yampayon K11,12, Kijsanayotin P12, Nakkam N13, Saksit N13,14, Tassaneeyakul W13, Aihara M15, Lin YJ16, Chang CJ17, Wu T18, Hung SI19, Chung WH1,2,3,4,5,6. Journal: Clin Pharmacol Ther. 2019 Feb;105(2):476-485. doi: 10.1002/cpt.1190. Epub 2018 Sep 30.    PubMed      DOI
7.	Model-Based Meta-Analysis in Ankylosing Spondylitis: A Quantitative Comparison of Biologics and Small Targeted Molecules. Author: Wu Y1,2, Feng X2, Li J1, Wang X1, Yang C2, Zhao L1. Journal: Clin Pharmacol Ther. 2019 May;105(5):1244-1255. doi: 10.1002/cpt.1305. Epub 2019 Jan 18.    PubMed      DOI
8.	Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals. Author: Danese E1, Raimondi S2, Montagnana M1, Tagetti A2, Langaee T3, Borgiani P4, Ciccacci C4, Carcas AJ5,6, Borobia AM5,6, Tong HY5,6, Dávila-Fajardo C7, Rodrigues Botton M8, Bourgeois S9, Deloukas P9,10, Caldwell MD11, Burmester JK12, Berg RL13, Cavallari LH3, Drozda K14, Huang M15, Zhao LZ15, Cen HJ16, Gonzalez-Conejero R17, Roldan V17, Nakamura Y18, Mushiroda T18, Gong IY19, Kim RB19, Hirai K20, Itoh K20, Isaza C21, Beltrán L21,22, Jiménez-Varo E23, Cañadas-Garre M24, Giontella A2, Kringen MK25,26, Haug KBF27, Gwak HS28, Lee KE29, Minuz P2, Lee MTM30,31, Lubitz SA32, Scott S33, Mazzaccara C34,35, Sacchetti L34,35, Genç E36, Özer M36, Pathare A37, Krishnamoorthy R38, Paldi A39, Siguret V40,41, Loriot MA42,43, Kutala VK44, Suarez-Kurtz G45, Perini J46, Denny JC47, Ramirez AH48, Mittal B49, Rathore SS49, Sagreiya H50, Altman R50, Shahin MHA3, Khalifa SI51, Limdi NA52, Rivers C52, Shendre A53, Dillon C52, Suriapranata IM54, Zhou HH55, Tan SL56, Tatarunas V57, Lesauskaite V57, Zhang Y58, Maitland-van der Zee AH58,59, Verhoef TI60, de Boer A58, Taljaard M61, Zambon CF62, Pengo V63, Zhang JE64, Pirmohamed M64, Johnson JA3, Fava C2. Journal: Clin Pharmacol Ther. 2019 Jun;105(6):1477-1491. doi: 10.1002/cpt.1323. Epub 2019 Feb 17.    PubMed      DOI
9.	Hypersensitivity and Cardiovascular Risks Related to Allopurinol and Febuxostat Therapy in Asians: A Population-Based Cohort Study and Meta-Analysis. Author: Chen CH1,2, Chen CB3,4,5,6,7,8, Chang CJ5,9,10, Lin YJ5,9,10, Wang CW3,4, Chi CC3,5, Lu CW3,4,5,6, Chen WT3,5, Pan RY3,4, Su SC3,8, Hsu LA11, Chang YC3,5, Yu KH12, Wu YJ13, Lin KM14, Hung SI15, Chen SM2, Chung WH3,4,5,6,7,8. Journal: Clin Pharmacol Ther. 2019 Jan 28. doi: 10.1002/cpt.1377. [Epub ahead of print]    PubMed      DOI
10.	Oncology Therapy Drugs in China, Japan, and the United States: Pharmacokinetic Characteristics, Dose Regimens, and Development Strategies. Author: Zhou L1, Higashimori M2, Shen K3, Zhang Z3, Sheng J4, Xu H1, Horiuchi M2, Ichikawa K2, Al-Huniti N1, Zhou D1. Journal: Clin Pharmacol Ther. 2019 Jun;105(6):1303-1320. doi: 10.1002/cpt.1352. Epub 2019 Feb 25.    PubMed      DOI

同类著名期刊名称 h-index CiteScore PHARMACOLOGICAL REVIEWS 210 18.73 TRENDS IN PHARMACOLOGICAL SCIENCES 201 9.98 ADVANCED DRUG DELIVERY REVIEWS 278 13.90 DRUG RESISTANCE UPDATES 100 13.15 PHARMACOLOGY & THERAPEUTICS 180 10.16 MEDICINAL RESEARCH REVIEWS 119 8.83 BRITISH JOURNAL OF PHARMACOLOGY 190 6.12 DRUG DISCOVERY TODAY 157 7.08 PHARMACOLOGICAL RESEARCH 118 5.27 EXPERT OPINION ON THERAPEUTIC PATENTS 61 3.31

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 287606 CANCER RESEARCH 163772 International Journal of Nanomedicine 162227 Molecular Medicine Reports 162125 CANCER LETTERS 157299 JOURNAL OF ETHNOPHARMACOLOGY 139136 BIOMEDICINE & PHARMACOTHERAPY 137168 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 133789 Theranostics 133111 International Journal of Environmental Research and Public Health 131431